| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yang Xia | |
| Rodney E Kellems | |||
| P2860 | cites work | Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology | Q80367574 |
| A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure | Q80698999 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Anti-Angiotensin Type 1 Receptor Antibodies Associated With Antibody Mediated Rejection in Donor HLA Antibody Negative Patients | Q82213207 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study | Q84284308 | ||
| AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration | Q24290268 | ||
| Angiotensin receptors, autoimmunity, and preeclampsia | Q24605647 | ||
| Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody | Q27645120 | ||
| Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships | Q28210588 | ||
| Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension | Q28575913 | ||
| Epidemiology and estimated population burden of selected autoimmune diseases in the United States | Q33500191 | ||
| Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats | Q33535920 | ||
| Endothelial dysfunction induced by antibodies against angiotensin AT1 receptor in immunized rats | Q33577570 | ||
| Fetal origins of cardiovascular disease | Q73134554 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Genetic immunization against the human thyrotropin receptor causes thyroiditis and allows production of monoclonal antibodies recognizing the native receptor | Q74506232 | ||
| In utero programming of chronic disease | Q74813945 | ||
| Estimation of serum TSH receptor autoantibody concentration and affinity | Q79378964 | ||
| The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection | Q79882539 | ||
| The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
| Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins | Q33653001 | ||
| Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia | Q33748650 | ||
| Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity | Q33748680 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Fetal nutrition and adult disease | Q33900856 | ||
| Thyrotropin receptor-associated diseases: from adenomata to Graves disease | Q33905841 | ||
| Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
| Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy | Q33974796 | ||
| Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy | Q34263678 | ||
| beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. | Q34651493 | ||
| Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia | Q34785813 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia | Q35079406 | ||
| The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim | Q35095551 | ||
| CD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancy | Q35130793 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Dimerization of G-protein-coupled receptors: roles in signal transduction | Q35592680 | ||
| Roles of G-protein-coupled receptor dimerization | Q35622424 | ||
| G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling | Q35625502 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
| Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia | Q35715914 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| Is preeclampsia an autoimmune disease? | Q36050775 | ||
| Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor | Q36365071 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. | Q36548874 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| TSH receptor antibodies | Q36953687 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia | Q37079628 | ||
| Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease | Q37175812 | ||
| Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease | Q37190001 | ||
| Techniques to quantify TSH receptor antibodies | Q37198602 | ||
| Pathological autoantibodies in cardiomyopathy. | Q37264371 | ||
| Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy | Q37292050 | ||
| TSH receptor autoantibodies | Q37426868 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Pathogenesis of preeclampsia | Q37676212 | ||
| Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine | Q37821802 | ||
| Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies | Q38494999 | ||
| Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy | Q40841949 | ||
| Beta 1-adrenoceptor autoimmunity in cardiomyopathy | Q41108926 | ||
| A monoclonal antibody directed against an autoimmune epitope on the human beta1-adrenergic receptor recognized in idiopathic dilated cardiomyopathy | Q42056322 | ||
| Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein | Q43291018 | ||
| Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes | Q43670106 | ||
| A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor | Q43909473 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation | Q44218760 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor | Q44608583 | ||
| Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes | Q44657870 | ||
| Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function | Q45024369 | ||
| A new assay for thyrotropin receptor autoantibodies | Q45180164 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| The effects of autoantibodies against the second extracellular loop of alpha(1)-adrenoceptor on vasoconstriction | Q46069905 | ||
| Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy | Q46086326 | ||
| Treatment of Graves' disease with rituximab specifically reduces the production of thyroid stimulating autoantibodies. | Q46285253 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension. | Q46798857 | ||
| Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness | Q46841539 | ||
| Thyroid-stimulating immunoglobulins in Graves' disease | Q46966821 | ||
| Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies. | Q50357093 | ||
| Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. | Q51139503 | ||
| Human monoclonal thyroid stimulating autoantibody. | Q51835330 | ||
| Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. | Q52900457 | ||
| Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. | Q52905846 | ||
| Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? | Q52928690 | ||
| Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. | Q52940276 | ||
| Stimulation of the human thyroid by infusions of plasma containing LATS protector. | Q54661203 | ||
| Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. | Q54782424 | ||
| A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity | Q58846968 | ||
| Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia | Q64377002 | ||
| Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization | Q67700979 | ||
| Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy | Q69324044 | ||
| Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
| Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect | Q72523353 | ||
| Alpha 1-adrenergic receptor antibodies in patients with primary hypertension | Q73089177 | ||
| P433 | issue | 5 | |
| P921 | main subject | autoantibody | Q785022 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 659-674 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Expert Review of Clinical Immunology | Q15733763 |
| P1476 | title | Receptor-activating autoantibodies and disease: preeclampsia and beyond | |
| P478 | volume | 7 |
| Q38818993 | Advances in Pretransplant Donor-Specific Antibody Testing in Solid Organ Transplantation: From Bench to Bedside |
| Q43063894 | Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascades |
| Q38207936 | Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases |
| Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
| Q39076219 | Anti-angiotensin II type 1 receptor autoantibodies (AT1R-AAs) in patients with systemic sclerosis: lack of association with disease manifestations. |
| Q38232126 | Applications of cell-based bioassays measuring the induced expression of endogenous genes |
| Q36744349 | Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy? |
| Q35658644 | Assessment and management of hypertension in transplant patients |
| Q37045274 | Atrial tachycardia provoked in the presence of activating autoantibodies to β2-adrenergic receptor in the rabbit |
| Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
| Q48638550 | Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies. |
| Q50099198 | Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology |
| Q37996960 | Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery |
| Q36930454 | High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana |
| Q33581645 | Human placental microRNAs and preeclampsia |
| Q38128162 | Hypertension after kidney transplantation: a pathophysiologic approach |
| Q39198610 | Inflammation, Autoimmunity, and Hypertension: The Essential Role of Tissue Transglutaminase |
| Q54111475 | MMP-8 C-799T and MMP-8 C+17G polymorphisms in mild and severe preeclampsia: Association between MMP-8 C-799T with susceptibility to severe preeclampsia. |
| Q92479800 | Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review |
| Q51740847 | Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats. |
| Q36537709 | RAS in Pregnancy and Preeclampsia and Eclampsia |
| Q26864907 | Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies |
| Q26828020 | Role of endothelin in uteroplacental circulation and fetal vascular function |
| Q92702916 | Suppression of β1-Adrenoceptor Autoantibodies is Involved in the Antiarrhythmic Effects of Omega-3 Fatty Acids in Male and Female Hypertensive Rats |
| Q38162971 | The patent situation concerning the treatment of diseases associated with autoantibodies directed against G-protein-coupled receptors |
Search more.